UDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Karo Bio (STO:KARO)
The January–December period and the fourth quarter 2011 in brief
Net sales amounted to MSEK 0.0 (0.0) Net loss was MSEK 226.6 (163.5), whereof the fourth quarter MSEK 50.6 (50.1)
Karo Bio (STO:KARO)
The January–December period and the fourth quarter 2011 in brief
Net sales amounted to MSEK 0.0 (0.0) Net loss was MSEK 226.6 (163.5), whereof the fourth quarter MSEK 50.6 (50.1)
